Wednesday, December 24, 2014
New Federal Circuit Opinions - December 24, 2014
Fleming v. Escort Inc., Nos. 2014-1331, -1371 (Fed. Cir. Dec. 24, 2014).
Tuesday, December 23, 2014
New Federal Circuit Opinions - December 23, 2014
Content Extraction & Transmission LLC v. Wells Fargo Bank, Nat’l Ass’n, Nos. 2013-1588, -1589, 2014-1112, -1687 (Fed. Cir. Dec. 23, 2014).
Monday, December 22, 2014
New Federal Circuit Opinions - December 22, 2014
Aqua Shield v. Inter Pool Cover Team, No. 2014-1263 (Fed. Cir. Dec. 22, 2014).
Friday, December 19, 2014
New Federal Circuit Opinions - December 19, 2014
Stryker Corp. v. Zimmer, Inc., No. 2013-1668 (Fed. Cir. Dec. 19, 2014).
Wednesday, December 17, 2014
New Federal Circuit Opinions - December 17, 2014
Univ. of Utah Research Found. v. Ambry Genetics Corp., Nos. 2014-1361, -1366 (Fed. Cir. Dec. 17, 2014).
Monday, December 15, 2014
New Federal Circuit Opinions - December 15, 2014
Promega Corp. v. Life Techs. Corp., Nos. 2013-1011, -1029, -1376 (Fed. Cir. Dec. 15, 2014).
Tuesday, December 9, 2014
New Federal Circuit Opinions - December 9, 2014
Japanese Found. for Cancer Research v. Lee, Nos. 2013-1678, 2014-1014 (Fed. Cir. Dec. 9, 2014).
Friday, December 5, 2014
New Federal Circuit Opinions - December 5, 2014
Memorylink Corp. v. Motorola Solutions, Inc., No. 2014-1186 (Fed. Cir. Dec. 5, 2014).
Sandoz Inc. v. Amgen Inc., No. 2014-1693 (Fed. Cir. Dec. 5, 2014).
DDR Holdings, LLC v. Hotels.com, L.P., No. 2013-1505 (Fed. Cir. Dec. 5, 2014).
Sandoz Inc. v. Amgen Inc., No. 2014-1693 (Fed. Cir. Dec. 5, 2014).
DDR Holdings, LLC v. Hotels.com, L.P., No. 2013-1505 (Fed. Cir. Dec. 5, 2014).
Thursday, December 4, 2014
New Federal Circuit Opinions - December 4, 2014
Tyco Healthcare Group LP v. Ethicon Endo-Surgery, Inc., Nos. 2013-1324, -1381 (Fed. Cir. Dec. 4, 2014).
Ericsson, Inc. v. D-Link Sys., Inc., Nos. 2013-1625, -1631, -1632, 1633 (Fed. Cir. Dec. 4, 2014).
Ericsson, Inc. v. D-Link Sys., Inc., Nos. 2013-1625, -1631, -1632, 1633 (Fed. Cir. Dec. 4, 2014).
Wednesday, December 3, 2014
New Federal Circuit Opinions - December 3, 2014
Par Pharm., Inc. v. TWi Pharm., Inc., No. 2014-1391 (Fed. Cir. Dec. 3, 2014).
Thursday, November 20, 2014
New Federal Circuit Opinions - November 20, 2014
Versata Software, Inc. v. Callidus Software Inc., No. 2014-1468 (Fed. Cir. Nov. 20, 2014).
Wednesday, November 19, 2014
New Federal Circuit Opinions - November 19, 2014
e.Digital Corp. v. Futurewei Techs., Inc., No. 2014-1019 (Fed. Cir. Nov. 19, 2014).
Monday, November 17, 2014
New Federal Circuit Opinions - November 17, 2014
Antares Pharma, Inc. v. Medac Pharma Inc., No. 2014-1648 (Fed. Cir. Nov. 17, 2014).
Friday, November 14, 2014
New Federal Circuit Opinions - November 14, 2014
Ultramercial, LLC v. Hulu, LLC, No. 2010-1544 (Fed. Cir. Nov. 14, 2014).
Thursday, November 6, 2014
New Federal Circuit Opinions - November 6, 2014
Azure Networks, LLC v. CSR PLC, No. 2013-1459 (Fed. Cir. Nov. 6, 2014).
Wednesday, November 5, 2014
New Federal Circuit Opinions - November 5, 2014
In re Reines, No. 14-MA004 (Fed. Cir. Nov. 5, 2014).
Williamson v. Citrix Online, LLC, No. 2013-1130 (Fed. Cir. Nov. 5, 2014).
Williamson v. Citrix Online, LLC, No. 2013-1130 (Fed. Cir. Nov. 5, 2014).
Wednesday, October 22, 2014
New Federal Circuit Opinions - October 22, 2014
Halo Elecs., Inc. v. Pulse Elecs., Inc., Nos. 2013-1472, -1656 (Fed. Cir. Oct. 22, 2014).
Tuesday, October 21, 2014
New Federal Circuit Opinions - October 21, 2014
IRIS Corp. v. Japan Airlines Corp., No. 2010-1051 (Fed. Cir. Oct. 21, 2014).
Monday, October 20, 2014
New Federal Circuit Opinions - October 20, 2014
World Class Tech. Corp. v. Ormco Corp., Nos. 2013-1679, 2014-1692 (Fed. Cir. Oct. 20, 2014).
AntiCancer Inc. v. Pfizer Inc., No. 2013-1056 (Fed. Cir. Oct. 20, 2014).
Bristol-Myers Squibb Co. v. Teva Pharm. USA, Inc., No. 2013-1306 (Fed. Cir. Oct. 20, 2014) (Order denying Bristol-Myers Squibb's petition for panel hearing and rehearing en banc).
AntiCancer Inc. v. Pfizer Inc., No. 2013-1056 (Fed. Cir. Oct. 20, 2014).
Bristol-Myers Squibb Co. v. Teva Pharm. USA, Inc., No. 2013-1306 (Fed. Cir. Oct. 20, 2014) (Order denying Bristol-Myers Squibb's petition for panel hearing and rehearing en banc).
Friday, October 17, 2014
New Federal Circuit Opinions - October 17, 2014
CardSoft, Inc. v. VeriFone Holdings, Inc., No. 2014-1135 (Fed. Cir. Oct. 17, 2014).
Tuesday, October 14, 2014
New Federal Circuit Opinions - October 14, 2014
SSL Servs., LLC v. Citrix Sys., Inc., Nos. 2013-1419, -1420 (Fed. Cir. Oct. 14, 2014).
Robert Bosch LLC v. Snap-On, Inc., No. 2014-1040 (Fed. Cir. Oct. 14, 2014).
Robert Bosch LLC v. Snap-On, Inc., No. 2014-1040 (Fed. Cir. Oct. 14, 2014).
Monday, September 29, 2014
New Federal Circuit Opinions - September 29, 2014
EMD Millipore Corp. v. AllPure Techs., Inc., No. 2014-1140 (Fed. Cir. Sept. 29, 2014).
Friday, September 26, 2014
New Federal Circuit Opinions - September 26, 2014
Am. Calcar, Inc. v. Am. Honda Motor Co., No. 2013-1061 (Fed. Cir. Sept. 23, 2014).
Thursday, September 25, 2014
New Federal Circuit Opinions - September 25, 2014
Benefit Funding Sys. LLC v. Advance Am. Cash Advance Ctrs., Inc., Nos. 2014-1122, -1124, -1125 (Fed. Cir. Sept. 25, 2014).
uPI Semiconductor Corp. v. Int'l Trade Comm'n, No. 2013-1157 (Fed. Cir. Sept. 25, 2014).
uPI Semiconductor Corp. v. Int'l Trade Comm'n, No. 2013-1157 (Fed. Cir. Sept. 25, 2014).
Wednesday, September 17, 2014
New Federal Circuit Opinions - September 17, 2014
SCA Hygiene Prods. AB v. First Quality Baby Prods., LLC, No. 2013-1564 (Fed. Cir. Sept. 17, 2014).
STC.UNM v. Intel Corp., No. 2013-1241 (Fed. Cir. Sept. 17, 2014).
STC.UNM v. Intel Corp., No. 2013-1241 (Fed. Cir. Sept. 17, 2014).
Tuesday, September 16, 2014
New Federal Circuit Opinions - September 16, 2014
VirnetX, Inc. v. Cisco Sys., Inc., No. 2013-1489 (Fed. Cir. Sept. 16, 2014).
Jang v. Boston Scientific Corp., No. 2014-134 (Fed. Cir. Sept. 16, 2014) (Order).
Jang v. Boston Scientific Corp., No. 2014-134 (Fed. Cir. Sept. 16, 2014) (Order).
Wednesday, September 10, 2014
New Federal Circuit Opinions - September 10, 2014
Scientific Plastic Prods., Inc. v. Biotage AB, Nos. 2013-1219, -1220, -1221 (Fed. Cir. Sept. 10, 2014).
Interval Licensing LLC v. AOL, Inc., Nos. 2013-1282, -1283, -1284, -1285 (Fed. Cir. Sept. 10, 2014).
Interval Licensing LLC v. AOL, Inc., Nos. 2013-1282, -1283, -1284, -1285 (Fed. Cir. Sept. 10, 2014).
Friday, September 5, 2014
New Federal Circuit Opinions - September 5, 2014
EPOS Techs. Ltd. v. Pegasus Techs. Ltd., No. 2013-1330 (Fed. Cir. Sept. 5, 2014).
Wednesday, September 3, 2014
New Federal Circuit Opinions - September 3, 2014
buySAFE, Inc. v. Google, Inc., No. 2013-1575 (Fed. Cir. Sept. 3, 2014).
Friday, August 22, 2014
New Federal Circuit Opinions - August 22, 2014
Ferring B.V. v. Watson Labs., Inc. – Fla., No. 2014-1416 (Fed. Cir. Aug. 22, 2014).
Ferring B.V. v. Apotex, Inc., No. 2014-1377 (Fed. Cir. Aug. 22, 2014).
Mformation Techs., Inc. v. Research in Motion Ltd., Nos. 2012-1679, 2013-1123 (Fed. Cir. Aug. 22, 2014).
Ferring B.V. v. Apotex, Inc., No. 2014-1377 (Fed. Cir. Aug. 22, 2014).
Mformation Techs., Inc. v. Research in Motion Ltd., Nos. 2012-1679, 2013-1123 (Fed. Cir. Aug. 22, 2014).
Thursday, August 21, 2014
New Federal Circuit Opinions - August 21, 2014
AbbVie, Inc. v. Mathilda & Terrance Kennedy Inst. of Rheumatology Trust, No. 13-1545 (Fed. Cir. Aug. 21, 2014).
Friday, August 15, 2014
New Federal Circuit Opinions - August 15, 2014
Apotex, Inc. v. UCB, Inc., No. 2013-1674 (Fed. Cir. Aug. 15, 2014).
Monday, August 11, 2014
New Federal Circuit Opinions - August 11, 2014
State of Vermont v. MPHJ Tech. Invs., LLC, No. 2014-1481 (Fed. Cir. Aug. 11, 2014).
Wednesday, August 6, 2014
New Federal Circuit Opinions - August 6, 2014
Tyco Healthcare Grp. LP v. Mutual Pharm. Co., No. 2013-1386 (Fed. Cir. Aug. 6, 2014).
ScriptPro LLC v. Innovation Assocs., Inc., No. 2013-1561 (Fed. Cir. Aug. 6, 2014).
ScriptPro LLC v. Innovation Assocs., Inc., No. 2013-1561 (Fed. Cir. Aug. 6, 2014).
Friday, August 1, 2014
New Federal Circuit Opinions - August 1, 2014
Amdocs (Israel) Ltd. v. Openet Telecom, Inc., No. 2013-1212 (Fed. Cir. Aug. 1, 2014).
Friday, July 25, 2014
New Federal Circuit Opinions - July 25, 2014
ePlus, Inc. v. Lawson Software, Inc., Nos. 2013-1506, -1587 (Fed. Cir. July 25, 2014).
Thursday, July 24, 2014
New Federal Circuit Opinions - July 24, 2014
In re Nokia Inc., No. 2014-133 (Fed. Cir. July 24, 2014) (Order).
Friday, July 18, 2014
New Federal Circuit Opinions - July 18, 2014
Align Tech., Inc. v. Int'l Trade Comm'n, Nos. 2013-1240, -1363 (Fed. Cir. July 18, 2014).
Thursday, July 17, 2014
New Federal Circuit Opinions - July 17, 2014
Arlington Indus., Inc. v. Bridgeport Fittings, Inc., No. 2013-1357 (Fed. cir. July 17, 2014).
Monday, July 14, 2014
New Federal Circuit Opinions - July 14, 2014
Medisim Ltd. v. BestMed LLC, No. 2013-1451 (Fed. Cir. July 14, 2014).
Golden Bridge Tech., Inc. v. Apple Inc., No. 2013-1496 (Fed. Cir. July 14, 2014).
Golden Bridge Tech., Inc. v. Apple Inc., No. 2013-1496 (Fed. Cir. July 14, 2014).
Friday, July 11, 2014
New Federal Circuit Opinions - July 11, 2014
H-W Tech., L.C. v. Overstock.com, Inc., Nos. 2014-1054, -1055 (Fed. Cir. July 11, 2014).
Troy v. Samson Mfg., No. 2013-1565 (Fed. Cir. July 10, 2014).
Digitech Image Techs., LLC v. Elecs. for Imaging, Inc., Nos. 2013-1600 through 1618 (Fed. Cir. July 11, 2014).
Troy v. Samson Mfg., No. 2013-1565 (Fed. Cir. July 10, 2014).
Digitech Image Techs., LLC v. Elecs. for Imaging, Inc., Nos. 2013-1600 through 1618 (Fed. Cir. July 11, 2014).
Thursday, July 10, 2014
New Federal Circuit Opinions - July 10, 2014
Stauffer v. Brooks Bros. Group, Inc., No. 2013-1180 (Fed. Cir. July 10, 2014).
VirtualAgility Inc. v. Salesforce.com, Inc., No. 2014-1232 (Fed. Cir. July 10, 2014).
VirtualAgility Inc. v. Salesforce.com, Inc., No. 2014-1232 (Fed. Cir. July 10, 2014).
Monday, July 7, 2014
New Federal Circuit Opinions - July 7, 2014
X2Y Attenuators, LLC v. Int'l Trade Comm'n, Nos. 2013-1340 (Fed. Cir. July 7, 2014).
Retractable Techs., Inc. v. Becton, Dickinson & Co., No. 2013-1567 (Fed. Cir. July 7, 2014).
Retractable Techs., Inc. v. Becton, Dickinson & Co., No. 2013-1567 (Fed. Cir. July 7, 2014).
Tuesday, July 1, 2014
New Federal Circuit Opinions - July 1, 2014
AbbVie Deutschland GmbH & Co. v. Janssen Biotech, Inc., Nos. 2013-1338, -1346 (Fed. Cir. July 1, 2014).
MadStad Eng’g, Inc. v. U.S. Patent & Trademark Office, Nos. 2013-1511, -1512 (Fed. Cir. July 1, 2014).
MadStad Eng’g, Inc. v. U.S. Patent & Trademark Office, Nos. 2013-1511, -1512 (Fed. Cir. July 1, 2014).
Friday, June 27, 2014
New Federal Circuit Opinions - June 27, 2014
Hill-Rom Servs., Inc. v. Stryker Corp., No. 2013-1459 (Fed. Cir. June 27, 2014).
Wednesday, June 25, 2014
New Federal Circuit Opinions - June 25, 2014
In re Nintendo of America, Inc., No. 2014-132 (Fed. Cir. June 25, 2014) (Motion Panel Order).
Tuesday, June 24, 2014
New Federal Circuit Opinions - June 24, 2014
CEATS, Inc. v. Continental Airlines, Inc., No. 2013-1529 (Fed. Cir. June 24, 2014).
Friday, June 20, 2014
New Federal Circuit Opinions - June 20, 2014
Augme Techs., Inc. v. Yahoo! Inc., Nos. 2013-1121, -1195 (Fed. Cir. June 20, 2014).
Thursday, June 19, 2014
New Supreme Court Opinions - June 19, 2014
Alice Corp. Pty. Ltd. v. CLS Bank Int'l, 73 U. S. ____ (2014).
New Federal Circuit Opinions - June 19, 2014
Gemalto S.A. v. HTC Corp., No. 2013-1397 (Fed. Cir. June 19, 2014).
Friday, June 13, 2014
New Federal Circuit Opinions - June 13, 2014
Triton Tech of Texas, LLC v. Nintendo of Am., Inc., No. 2013-1476 (Fed. Cir. June 13, 2014).
Thursday, June 12, 2014
New Federal Circuit Opinions - June 12, 2014
Bristol-Myers Squibb Co. v. Teva Pharms. USA, Inc., No. 2013-1306 (Fed. Cir. June 12, 2014).
Tuesday, June 10, 2014
New Federal Circuit Opinions - June 10, 2014
Allergan, Inc. v. Apotex Inc., Nos. 2013-1245, -1246, -1247, -1249 (Fed. Cir. June 10, 2014).
In re Dinsmore, No. 2013-1637 (Fed. Cir. June 10, 2014).
In re Dinsmore, No. 2013-1637 (Fed. Cir. June 10, 2014).
Monday, June 9, 2014
New Federal Circuit Opinions - June 9, 2014
Q.I. Press Controls, B.V. v. Lee, Nos. 2012-1630, -1631 (Fed. Cir. June 9, 2014).
Friday, June 6, 2014
New Federal Circuit Opinions - June 6, 2014
STC.UNM v. Intel Corp., No. 2013-1241 (Fed. Cir. June 6, 2014).
Thursday, June 5, 2014
New Federal Circuit Opinions - June 5, 2014
Source Vagabond Sys. Ltd. v. Hydrapak, Inc., Nos. 2013-1270, -1387 (Fed. Cir. June 5, 2014).
Wednesday, June 4, 2014
New Federal Circuit Opinions - June 4, 2014
Consumer Watchdog v. Wisconsin Alumni Research Foundation, No. 2013-1377 (Fed. Cir. June 4, 2014).
In re Rambus, Inc., No. 2013-1192 (Fed. Cir. June 4, 2014).
Krauser v. BioHorizons, Inc., No. 2013-1461 (Fed. Cir. June 4, 2014).
In re Rambus, Inc., No. 2013-1192 (Fed. Cir. June 4, 2014).
Krauser v. BioHorizons, Inc., No. 2013-1461 (Fed. Cir. June 4, 2014).
Monday, June 2, 2014
New Supreme Court Opinions - June 2, 2014
Limelight Networks, Inc. v. Akamai Techs. Inc., 572 U.S. ___ (2014) (holding that a defendant is not liable for inducing infringement under 35 U.S.C. §271(b) when no one has directly infringed under §271(a) or any other statutory provision).
Nautilus, Inc. v. Biosig Instruments, Inc., 572 U.S. ___ (2014)(holding that the test for indefiniteness is "reasonable certainty," not “amenable to construction” or “insolubly ambiguous”).
Nautilus, Inc. v. Biosig Instruments, Inc., 572 U.S. ___ (2014)(holding that the test for indefiniteness is "reasonable certainty," not “amenable to construction” or “insolubly ambiguous”).
Tuesday, May 27, 2014
New Federal Circuit Opinions - May 27, 2014
K/S HIMPP v. Hear-Wear Techs., LLC, No. 2013-1549 (Fed. Cir. May 27, 2014).
Suffolk Techs., LLC v. AOL Inc., No. 2013-1392 (Fed. Cir. May 27, 2014).
Suffolk Techs., LLC v. AOL Inc., No. 2013-1392 (Fed. Cir. May 27, 2014).
Monday, May 19, 2014
New Federal Circuit Opinions - May 19, 2014
Tobinick v. Olmarker, No. 2013-1499 (Fed. Cir. May 19, 2014).
Friday, May 9, 2014
New Federal Circuit Opinions - May 9, 2014
Monsanto Co. v. E.I. Du Pont de Nemours & Co., No. 2013-1349 (Fed. Cir. May 9, 2014).
InTouch Techs., Inc. v. VGo Commc’ns, Inc., No. 2013-1201 (Fed. Cir. May 9, 2014).
Oracle Am., Inc. v. Google Inc., Nos. 2013-1021, -1022 (Fed. Cir. May 9, 2014).
InTouch Techs., Inc. v. VGo Commc’ns, Inc., No. 2013-1201 (Fed. Cir. May 9, 2014).
Oracle Am., Inc. v. Google Inc., Nos. 2013-1021, -1022 (Fed. Cir. May 9, 2014).
Thursday, May 8, 2014
New Federal Circuit Opinions - May 8, 2014
Gen. Electric Co. v. Wilkins, No. 2013-1170 (Fed. Cir. May 8, 2014).
In re Roslin Institute (Edinburgh), No. 2013-1407 (Fed. Cir. May 8, 2014).
In re Roslin Institute (Edinburgh), No. 2013-1407 (Fed. Cir. May 8, 2014).
Monday, May 5, 2014
Risk Management for U.S. Patent Infringement Lawsuits
The article co-authored by Lei Mei of Mei & Mark LLP and titled “Risk Management
for U.S. Patent Infringement Lawsuits” was published in the March
2014 edition of Guangdong LED Magazine.
A copy of the article (English Version) is reproduced below:
The Chinese LED market is growing rapidly in the past few years. It is becoming an important player in the world market. It is obvious that the LED industry is more and more popular, as indicated by the growing litigation cases in the United States.
On September 11, 2013 Nichia sued Everlight Electronics in federal court in Marshall, Texas for alleged infringement of U.S. Patent No. 7,432,589 (“the ’589 patent”). The complaint alleges that Everlight’s LED model 61-238/RSGBB7C-B02/ET infringes the ’589 patent. The ’589 patent is directed to a semiconductor device capable of preventing an adhesive for die bonding from flowing to a wire bonding area. This is not the first lawsuit between these LED rivals.
On September 30, 2013, the United States District Court for the Central District of California issued a Final Judgment and Order imposing an injunction that prohibits Lights of America from making any misrepresentations about its LED products. The decision also includes a substantial monetary judgment, ordering Lights of America to pay the Federal Trade Commission over $21 million dollars.
Moreover, on September 20, 2013, the Trustees of Boston University filed patent infringement litigation against more than 20 companies in federal court in Boston regarding its LED patent 5,686,738. Defendants include Acer, Nikon, Sony, Dell, Fuji and others.
All these cases remind us about the importance of our own risk management. This section will discuss how Chinese companies may develop risk management strategies for U.S. patent infringement lawsuits.
I. Identify Potential Risks
As for any risk management, the starting point is to identify potential risks. Regarding U.S. patent infringement lawsuits, potential risks come in two forms: direct risks and indirect risks.
Direct risks, prevalent among semiconductor manufacturers, may come from product design. For example, during the R&D process, engineers might have studied competitors’ technology or patents to develop their own solutions. If the final product has features that would be covered by third party patents, it creates direct risks of potential patent infringement lawsuits.
Indirect risks, common among packaging companies that source semiconductor materials from manufacturers, may come from contracts and purchasing agreements. For example, when a packaging company enters a contract to purchase semiconductor components from a component manufacturer, the contract may be silent on potential IP liabilities regarding the components, or even release manufacturers from any future liabilities. As a result, the packaging company may be liable for patent infringement because of the components it purchased. Certainly, bargaining powers among the contracting parties may determine the wording of these contract provisions, but one must be aware of this type of indirect risks.
In addition, Chinese companies that do not directly import or sell components in the U.S. may face indirect risks of patent infringement lawsuits in the U.S. For example, customers of Chinese companies may buy and package the components in Asia and then sell final products in the U.S. A U.S. patent owner may then petition the United States International Trade Commission (ITC) to institute a Section 337 investigation that may exclude importation into the U.S. of any products containing infringing components.
To fully evaluate direct and indirect risks, Chinese companies should engage competent U.S. counsel to perform due diligence at every step of the production cycle.
II. Minimize Potential Risks
After identifying potential risks, Chinese companies will need to minimize potential risks of patent infringement lawsuits. Generally speaking, successful companies have adopted three common approaches.
First, design around to avoid your competitors’ patents. To minimize expenses, designing around should take place in the early phase of R&D, and one must continue to monitor competitors’ patenting efforts throughout the R&D process. Naturally, Chinese companies should not design around alone without input of competent U.S. counsel, because determining the scope of patent claims requires in-depth legal analysis.
Second, when designing around is not preferable (too costly or difficult), Chinese companies may retain competent U.S. counsel to render opinions on validity or infringement or both. Although an opinion letter is not required to defeat willful infringement (and potential treble damages) under recent U.S. case law, it is still desirable to have one because it will save future litigation costs and remove some uncertainties of the litigation.
Third, strategically patent the technologies that will cover your competitors’ products. Typically, in the semiconductor industry, products may be covered by many patents owned by different companies. Owning patents that cover a competitor’s products may enable you to negotiate a cross licensing deal so that both companies will be able to make and sell products without facing each other’s patent infringement lawsuit.
III. Manage Actual Risks
Unfortunately, some potential risks are inevitable to avoid. Therefore, Chinese companies must also be prepared to face and manage actual risks. For example, in the U.S., patent holding companies operate under a business model where they do not make any products themselves (thus unlikely to be sued for infringing other companies’ patents), but seeks royalties through licensing and patent enforcement. Therefore, Chinese companies need to learn how to handle U.S. patent infringement lawsuits.
This section will discuss two areas that are particularly relevant to Chinese companies: personal jurisdiction and electronic discovery. When you receive a copy of the complaint of a U.S. patent infringement lawsuit, you may consider taking several strategic steps in response.
First, evaluate your position in the stream of commerce. For example, do you sell products in the U.S.? Do you import products to the U.S.? Do you sell products in China, but your customers sell or import products into the U.S.?
On the one hand, if you sell or import products into the U.S., it is most likely that at least one U.S. district court has jurisdiction. The question then becomes which U.S. district court has jurisdiction. If the products are not sold in or imported into a particular district (e.g., Maryland), then this particular U.S. district court may not have jurisdiction. The plaintiff, however, may bring a suit in the appropriate U.S. district court.
On the other hand, if you sell the products only in China, but eventually the products are imported to and sold in the U.S., the situation becomes more complicated and requires careful analysis by U.S. counsel. For example, in Technology Patents, LLC v. Deutsche Telekom AG, No. AW-07-3012, slip op. at 2 (D. Md. Aug. 29, 2008), China Mobile and Singapore Telecom were named as two of many defendants in a U.S. district court in Maryland, but did not sell products in the U.S., as they merely allowed its existing users to send text messages while traveling in Maryland through agreements with U.S. wireless carriers. Therefore, they were not subject to personal jurisdiction in Maryland.
In contrast, if you sell your products to a customer, knowing that the customer will either import the products directly to the U.S. or package them with other components and import the final products to the U.S., it is more likely that you will be subject to personal jurisdiction in at least one U.S. district court.
Second, develop defense strategies by working with U.S. counsel to determine, for example, whether the company should file a motion to dismiss the lawsuit for lack of personal jurisdiction. Obviously, the decision depends on specific facts in individual cases. Additionally, U.S. counsel will help you identify potential issues, access risks, and develop appropriate defenses.
Third, prepare for document production if the lawsuit is not dismissed. As discussed earlier, discovery is a major component of U.S. patent litigation, and failure to produce relevant documents will result in severe sanctions. For example, in Qualcomm Inc. v. Broadcom Corp., No. 05 Civ. 1958, 2008 WL 66932 (S.D. Cal. Jan. 7, 2008), the judge ordered more than $8.5 million against Qualcomm, the plaintiff, for failure to produce relevant emails.
Typically, the judge will set a discovery schedule in the beginning of the case, so each party must be prepared to preserve the evidence and produce relevant documents timely. Accordingly, Asian companies should work with competent counsel to develop a discovery plan including identifying all relevant documents for production.
With careful preparation, Asian companies can learn to manage actual risks and handle patent infringement lawsuits smoothly.
A copy of the article (English Version) is reproduced below:
The Chinese LED market is growing rapidly in the past few years. It is becoming an important player in the world market. It is obvious that the LED industry is more and more popular, as indicated by the growing litigation cases in the United States.
On September 11, 2013 Nichia sued Everlight Electronics in federal court in Marshall, Texas for alleged infringement of U.S. Patent No. 7,432,589 (“the ’589 patent”). The complaint alleges that Everlight’s LED model 61-238/RSGBB7C-B02/ET infringes the ’589 patent. The ’589 patent is directed to a semiconductor device capable of preventing an adhesive for die bonding from flowing to a wire bonding area. This is not the first lawsuit between these LED rivals.
On September 30, 2013, the United States District Court for the Central District of California issued a Final Judgment and Order imposing an injunction that prohibits Lights of America from making any misrepresentations about its LED products. The decision also includes a substantial monetary judgment, ordering Lights of America to pay the Federal Trade Commission over $21 million dollars.
Moreover, on September 20, 2013, the Trustees of Boston University filed patent infringement litigation against more than 20 companies in federal court in Boston regarding its LED patent 5,686,738. Defendants include Acer, Nikon, Sony, Dell, Fuji and others.
All these cases remind us about the importance of our own risk management. This section will discuss how Chinese companies may develop risk management strategies for U.S. patent infringement lawsuits.
I. Identify Potential Risks
As for any risk management, the starting point is to identify potential risks. Regarding U.S. patent infringement lawsuits, potential risks come in two forms: direct risks and indirect risks.
Direct risks, prevalent among semiconductor manufacturers, may come from product design. For example, during the R&D process, engineers might have studied competitors’ technology or patents to develop their own solutions. If the final product has features that would be covered by third party patents, it creates direct risks of potential patent infringement lawsuits.
Indirect risks, common among packaging companies that source semiconductor materials from manufacturers, may come from contracts and purchasing agreements. For example, when a packaging company enters a contract to purchase semiconductor components from a component manufacturer, the contract may be silent on potential IP liabilities regarding the components, or even release manufacturers from any future liabilities. As a result, the packaging company may be liable for patent infringement because of the components it purchased. Certainly, bargaining powers among the contracting parties may determine the wording of these contract provisions, but one must be aware of this type of indirect risks.
In addition, Chinese companies that do not directly import or sell components in the U.S. may face indirect risks of patent infringement lawsuits in the U.S. For example, customers of Chinese companies may buy and package the components in Asia and then sell final products in the U.S. A U.S. patent owner may then petition the United States International Trade Commission (ITC) to institute a Section 337 investigation that may exclude importation into the U.S. of any products containing infringing components.
To fully evaluate direct and indirect risks, Chinese companies should engage competent U.S. counsel to perform due diligence at every step of the production cycle.
II. Minimize Potential Risks
After identifying potential risks, Chinese companies will need to minimize potential risks of patent infringement lawsuits. Generally speaking, successful companies have adopted three common approaches.
First, design around to avoid your competitors’ patents. To minimize expenses, designing around should take place in the early phase of R&D, and one must continue to monitor competitors’ patenting efforts throughout the R&D process. Naturally, Chinese companies should not design around alone without input of competent U.S. counsel, because determining the scope of patent claims requires in-depth legal analysis.
Second, when designing around is not preferable (too costly or difficult), Chinese companies may retain competent U.S. counsel to render opinions on validity or infringement or both. Although an opinion letter is not required to defeat willful infringement (and potential treble damages) under recent U.S. case law, it is still desirable to have one because it will save future litigation costs and remove some uncertainties of the litigation.
Third, strategically patent the technologies that will cover your competitors’ products. Typically, in the semiconductor industry, products may be covered by many patents owned by different companies. Owning patents that cover a competitor’s products may enable you to negotiate a cross licensing deal so that both companies will be able to make and sell products without facing each other’s patent infringement lawsuit.
III. Manage Actual Risks
Unfortunately, some potential risks are inevitable to avoid. Therefore, Chinese companies must also be prepared to face and manage actual risks. For example, in the U.S., patent holding companies operate under a business model where they do not make any products themselves (thus unlikely to be sued for infringing other companies’ patents), but seeks royalties through licensing and patent enforcement. Therefore, Chinese companies need to learn how to handle U.S. patent infringement lawsuits.
This section will discuss two areas that are particularly relevant to Chinese companies: personal jurisdiction and electronic discovery. When you receive a copy of the complaint of a U.S. patent infringement lawsuit, you may consider taking several strategic steps in response.
First, evaluate your position in the stream of commerce. For example, do you sell products in the U.S.? Do you import products to the U.S.? Do you sell products in China, but your customers sell or import products into the U.S.?
On the one hand, if you sell or import products into the U.S., it is most likely that at least one U.S. district court has jurisdiction. The question then becomes which U.S. district court has jurisdiction. If the products are not sold in or imported into a particular district (e.g., Maryland), then this particular U.S. district court may not have jurisdiction. The plaintiff, however, may bring a suit in the appropriate U.S. district court.
On the other hand, if you sell the products only in China, but eventually the products are imported to and sold in the U.S., the situation becomes more complicated and requires careful analysis by U.S. counsel. For example, in Technology Patents, LLC v. Deutsche Telekom AG, No. AW-07-3012, slip op. at 2 (D. Md. Aug. 29, 2008), China Mobile and Singapore Telecom were named as two of many defendants in a U.S. district court in Maryland, but did not sell products in the U.S., as they merely allowed its existing users to send text messages while traveling in Maryland through agreements with U.S. wireless carriers. Therefore, they were not subject to personal jurisdiction in Maryland.
In contrast, if you sell your products to a customer, knowing that the customer will either import the products directly to the U.S. or package them with other components and import the final products to the U.S., it is more likely that you will be subject to personal jurisdiction in at least one U.S. district court.
Second, develop defense strategies by working with U.S. counsel to determine, for example, whether the company should file a motion to dismiss the lawsuit for lack of personal jurisdiction. Obviously, the decision depends on specific facts in individual cases. Additionally, U.S. counsel will help you identify potential issues, access risks, and develop appropriate defenses.
Third, prepare for document production if the lawsuit is not dismissed. As discussed earlier, discovery is a major component of U.S. patent litigation, and failure to produce relevant documents will result in severe sanctions. For example, in Qualcomm Inc. v. Broadcom Corp., No. 05 Civ. 1958, 2008 WL 66932 (S.D. Cal. Jan. 7, 2008), the judge ordered more than $8.5 million against Qualcomm, the plaintiff, for failure to produce relevant emails.
Typically, the judge will set a discovery schedule in the beginning of the case, so each party must be prepared to preserve the evidence and produce relevant documents timely. Accordingly, Asian companies should work with competent counsel to develop a discovery plan including identifying all relevant documents for production.
With careful preparation, Asian companies can learn to manage actual risks and handle patent infringement lawsuits smoothly.
Labels:
general,
Patent Litigation,
Risk Management
Friday, May 2, 2014
New Federal Circuit Opinions - May 1, 2014
GE Lighting Solutions, LLC. v. AgiLight, Inc., No. 2013-1267 (Fed. Cir. May 1, 2014).
Tuesday, April 29, 2014
New Supreme Court Opinions - April 29, 2014
Octane Fitness, LLC v. Icon Health & Fitness, Inc., 572 U. S. ____ (2014) (holding that the Federal Circuit's Brooks Furniture framework that defined an “exceptional case” as one which either involves “material inappropriate conduct” or is both “objectively baseless” and “brought in subjective bad faith” is unduly rigid and impermissibly encumbers the statutory grant of discretion to district courts).
Highmark Inc. v. Allcare Health Mgmt. Sys., Inc., 572 U. S. ____ (2014) (holding that all aspects of a district court’s exceptional-case determination under §285 should be reviewed for abuse of discretion).
Highmark Inc. v. Allcare Health Mgmt. Sys., Inc., 572 U. S. ____ (2014) (holding that all aspects of a district court’s exceptional-case determination under §285 should be reviewed for abuse of discretion).
Friday, April 25, 2014
New Federal Circuit Opinions - April 25, 2014
Apple Inc. v. Motorola, Inc., Nos. 2012-1548, -1549 (Fed. Cir. Apr. 25, 2014).
Thursday, April 24, 2014
New Federal Circuit Opinions - April 24, 2014
Vaillancourt v. Becton Dickinson & Co., No. 2013-1408 (Fed. Cir. Apr. 24, 2014).
St. Jude Med., Cardiology Div. Inc. v. Volcano Corp., No. 2014-1183 (Fed. Cir. Apr. 24, 2014).
In re Dominion Dealer Solutions, LLC, No. 109 (Fed. Cir. Apr. 24, 2014).
In re Proctor & Gamble Co., No. 121 (Fed. Cir. Apr. 24, 2014).
St. Jude Med., Cardiology Div. Inc. v. Volcano Corp., No. 2014-1183 (Fed. Cir. Apr. 24, 2014).
In re Dominion Dealer Solutions, LLC, No. 109 (Fed. Cir. Apr. 24, 2014).
In re Proctor & Gamble Co., No. 121 (Fed. Cir. Apr. 24, 2014).
Tuesday, April 22, 2014
New Federal Circuit Opinions - April 22, 2014
Braintree Labs., Inc. v. Novel Labs., Inc., No. 2013-1438 (Fed. Cir. Apr. 22, 2014).
Gilead Scis. Inc. v. Natco Pharma Ltd., No. 2013-1418 (Fed. Cir. Apr. 22, 2014).
Gilead Scis. Inc. v. Natco Pharma Ltd., No. 2013-1418 (Fed. Cir. Apr. 22, 2014).
Monday, April 21, 2014
Friday, April 18, 2014
New Federal Circuit Opinions - April 18, 2014
DSM Desotech, Inc. v. 3D Sys. Corp., No. 2013-1298 (Fed. Cir. Apr. 18, 2014).
Friday, April 11, 2014
New Federal Circuit Opinions - April 11, 2014
Hoffmann-La Roche Inc. v. Apotex Inc., No. 2013-1128 (Fed. Cir. Apr. 11, 2014).
Wednesday, April 9, 2014
New Federal Circuit Opinions - April 9, 2014
Trebro Mfg., Inc. v. FireFly Equip., LLC, No. 2013-1437 (Fed. Cir. Apr. 9, 2014).
Monday, April 7, 2014
New Federal Circuit Opinions - April 7, 2014
Chicago Bd. Options Exch., Inc. v. Int’l Sec. Exch., LLC, No. 2013-1326 (Fed. Cir. Apr. 7, 2014).
Friday, April 4, 2014
New Federal Circuit Opinions - April 4, 2014
Microsoft Corp . v. DataTern, Inc., No. 2013-1184 (Fed. Cir. Apr. 4, 2014).
In re. Teles AG Informationstechnologien, No. 2012-1297 (Fed. Cir. Apr. 4, 2014).
In re. Teles AG Informationstechnologien, No. 2012-1297 (Fed. Cir. Apr. 4, 2014).
Thursday, April 3, 2014
New Federal Circuit Opinions - April 3, 2014
In re Toyota Motor Corp., No. 2014-113 (Fed. Cir. Apr. 3, 2014) (Ruling on motion).
Wednesday, April 2, 2014
New Federal Circuit Opinions - April 2, 2014
MRC Innovations, Inc. v. Hunter Mfg., LLP, No. 2013-1433 (Fed. Cir. Apr. 2, 2014).
Monday, March 31, 2014
New Federal Circuit Opinions - March 31, 2014
Senju Pharm. Co. v. Apotex Inc., No. 2013-1027 (Fed. Cir. Mar. 31, 2014).
Endo Pharm., Inc. v. Actavis Inc., Nos. 2013-1658, -1662 (Fed. Cir. Mar. 31, 2014).
Endo Pharm., Inc. v. Actavis Inc., Nos. 2013-1658, -1662 (Fed. Cir. Mar. 31, 2014).
Friday, March 28, 2014
New Federal Circuit Opinions - March 28, 2014
Shire Dev. LLC v. Watson Pharm., Inc., No. 2013-1409 (Fed. Cir. Mar. 28, 2014).
Wednesday, March 26, 2014
New Federal Circuit Opinions - March 26, 2014
StoneEagle Services, Inc. v. Gillman, No. 2013-1248 (Fed. Cir. Mar. 26, 2014).
Monday, March 24, 2014
New Federal Circuit Opinions - March 24, 2014
Brain Life, LLC v. Elekta Inc., No. 2013-1239 (Fed. Cir. Mar. 24, 2014).
Thursday, March 20, 2014
New Federal Circuit Opinions - March 20, 2014
Energy Recovery, Inc. v. Hauge, No. 2013-1515 (Fed. Cir. Mar. 20, 2014).
Tuesday, March 18, 2014
New Federal Circuit Opinions - March 18, 2014
Alcon Research Ltd. v. Barr Labs. Inc., Nos. 2012-1340, -1341 (Fed. Cir. Mar. 18, 2014).
Friday, March 14, 2014
New Federal Circuit Opinions - March 14, 2014
Vederi, LLC v. Google, Inc., No. 2013-1057 (Fed. Cir. Mar. 14, 2014).
Wednesday, March 12, 2014
New Federal Circuit Opinions - March 12, 2014
Therasense, Inc. v. Becton, Dickinson & Co., No. 2012-1504 (Fed. Cir. Mar. 12, 2014).
Tuesday, March 11, 2014
New Ways to Combat Counterfeiting and Piracy in China
Note: This article is published by IP Law360 on March 11, 2014. The content is reproduced below.
New Ways to Combat Counterfeiting and Piracy in China
Lei Mei, Managing
Partner, Mei & Mark LLP
Linfeng Qiu,
General Counsel, Hangzhou IP Protection & Management Center
E-commerce sales
in China have skyrocketed in recent years. For example, on a single day,
November 11, 2013, the leading Chinese E-commerce website, Taobao.com, sold a
record-breaking 35 billion RMB ($5.77 billion) worth of merchandise online. Unfortunately,
many Chinese websites have online merchandise that include counterfeit and
pirated products, as noted in the 2013 list of Notorious Markets by the United
States Trade Representative Office (“USTR”). Therefore, IP owners, including
U.S. consumer products companies, must develop a new effective strategy in
combating trademark counterfeiting and copyright piracy in China in this
digital age.
As an initial
matter, it is worth noting that China does have comprehensive trademark and
copyright laws and regulations that may be used to combat trademark
counterfeiting and copyright piracy, and China’s central government has made it
a high priority to protect intellectual property rights. For example, if there
is a dispute regarding trademark or copyright rights, the owner of the
registered trademark or copyright may bring a lawsuit in a People’s Court or
request a local administrative department for industry and commerce (i.e., the local
commerce department) to handle the matter.
Unlike the United
States, local commerce departments in China have the authority to order an
infringer to cease infringing upon that right immediately, to confiscate and
destroy the goods involved and the tools used to manufacture the said goods and
counterfeit the representations of the registered trademark or copyright, and
to also impose a fine, without a court’s order. A party dissatisfied with the
commerce department’s decision may bring a lawsuit in a People’s Court in
accordance with the Administrative Procedure Law of the People’s Republic of
China.
Despite these
laws and regulations, it is still questionable as to the effectiveness of
enforcement by local courts and commerce departments in specific cases. As the
United States International Trade Commission noted in a 2010 report, “[s]ignificant
structural and institutional impediments undermine effective enforcement,
including the protection of IPR infringing industries by local Chinese
officials, a lack of coordination among government agencies, insufficient
enforcement resources and training, and non-deterrent civil and criminal
penalties.” Today, local protectionism is still a legitimate concern in many
parts of China, although enforcement efforts are more effective in big cities.
U.S. companies
have traditionally used local Chinese law firms and/or investigative agents to
crack down on physical counterfeiting activities. The problem, however, has
always been that when a small factory is shutdown, another one springs up
elsewhere. There have also been instances where some rogue investigative agents
manufactured fake infringing activities to crack down on in order to collect
more fees from IP owners. As a result, it could be very difficult for IP owners
to achieve desired enforcement results in China.
In addition,
traditionally, the burden of obtaining admissible evidence is upon IP owners,
as China’s law does not require a civil defendant to voluntarily produce
relevant documents or provide relevant information (although a new amendment to
China’s trademark law, taking effect on May 1, 2014, does allow burden of
discovery to be shifted in certain circumstances).
Interestingly,
the solution to the traditional challenges of cracking down on physical
counterfeiting activities lies with the digital evolution. With the emergence
of websites like Taobao.com, online marketplace has become the main sales
channel for counterfeit and pirated products in China. Therefore, IP owners could
develop new enforcement mechanism to combat trademark counterfeiting and copyright
piracy in China in this digital age.
Surprisingly, it
is actually easier and more effective to combat trademark counterfeiting and
copyright piracy online for several reasons. First, e-commerce websites
typically show off product photos to the public, which can be easily and safely
downloaded as evidence of infringement. This removes the obstacle of gathering
evidence in a traditional physical marketplace in China, which not only is
difficult but also could be dangerous at times.
Second, IP
owners can easily obtain pricing and sales data of counterfeit and pirated
products from e-commerce websites and use those for damages calculation. In
general, damages are based on the amount of the profits that the infringer has
earned as a result of the infringement or the amount of the losses that the
infringed party has suffered as a result of the infringement. In a traditional
physical marketplace, it is very difficult to prove damages because of the
difficulty in obtaining relevant evidence from infringers.
Third, many
leading e-commerce websites are operated by established Chinese companies in China’s
more developed regions where IP enforcement has been more effective. For
example, Taobao.com is operated by Alibaba Group, a leading Chinese e-commerce
company in Hangzhou, the capital of Zhejiang province in Eastern China. For
obvious reasons, it is easier to demand these established companies to remove counterfeit
and pirated products from their online e-commerce websites.
Indeed, USTR has
removed Taobao.com from its Notorious Markets List since 2012, noting that
although “Taobao.com was included in previous Notorious Markets Lists for the
widespread availability of counterfeit and pirated goods in its electronic
marketplace,” it was removed from the List in 2012 “in recognition of [Taobao.com’s]
efforts to address these problems.” According to USTR, “Taobao.com has assured
the United States that it will continue to work with rights holders and law
enforcement officials in China to address remaining issues raised by software,
publishing and apparel and footwear companies.”
Finally, several
Chinese provinces have established semi-governmental IP protection and
management centers for cracking down on trademark counterfeiting and copyright
piracy. These centers provide an efficient platform for IP owners to serve
notices to e- commerce website operators and demand removal of the counterfeit
and pirated products. Typically, these centers function similar to private
firms, but due to their semi-governmental status, their involvements could make
enforcement efforts more efficient and cost-effective.
As China’s
e-commerce websites continues to gain popularity with estimated sales of 1.85
trillion RMB ($305 billion) in 2013, there are new and effective ways for U.S.
IP owners to combat trademark counterfeiting and copyright piracy in China.
With proper counseling and favorable local support, U.S. IP owners can achieve
success in enforcing and protecting their IP rights.
New Federal Circuit Opinions - March 11, 2014
Danisco US Inc. v. Novozymes A/S, No. 2013-1214 (Fed. Cir. Mar. 11, 2014).
Monday, March 3, 2014
New Federal Circuit Opinions - March 3, 2014
Ancora Techs., Inc. v. Apple Inc., Nos. 2013-1378, -1414 (Fed. Cir. Mar. 3, 2014).
Thursday, February 27, 2014
New Federal Circuit Opinions - February 27, 2014
In re Apple Inc., Misc. Docket No. 156 (Fed. Cir. Feb. 27, 2014).
In re Barnes & Noble, Inc., Misc. Docket No. 162 (Fed. Cir. Feb. 27, 2014).
In re Barnes & Noble, Inc., Misc. Docket No. 162 (Fed. Cir. Feb. 27, 2014).
Monday, February 24, 2014
New Federal Circuit Opinions - February 24, 2014
elcommerce.com, Inc. v. SAP AG, No. 2011-1369 (Fed. Cir. Feb. 24, 2014).
Starhome GmbH v. AT&T Mobility LLC, No. 2012-1694 (Fed. Cir. Feb. 24, 2014).
GlaxoSmithKline LLC v. Banner Pharmacaps, Inc., Nos. 2013-1593, -1594, -1595, -1598 (Fed. Cir. Feb. 24, 2014).
Starhome GmbH v. AT&T Mobility LLC, No. 2012-1694 (Fed. Cir. Feb. 24, 2014).
GlaxoSmithKline LLC v. Banner Pharmacaps, Inc., Nos. 2013-1593, -1594, -1595, -1598 (Fed. Cir. Feb. 24, 2014).
Friday, February 21, 2014
New Federal Circuit Opinions - February 21, 2014
Frans Nooren Afdichtingssytemen BV v. Stopaq Amcorr Inc., No. 2013-1200 (Fed. Cir. Feb. 21, 2014).
Lighting Ballast Control, LLC v. Philips Electronics North America Corp., No. 2012-1014 (Fed. Cir. Feb. 21, 2014) (en banc).
Lighting Ballast Control, LLC v. Philips Electronics North America Corp., No. 2012-1014 (Fed. Cir. Feb. 21, 2014) (en banc).
Wednesday, February 19, 2014
New Federal Circuit Opinions - February 19, 2014
Ring & Pinion Serv. Inc. v. ARB Corp., No., 2013-1238 (Fed. Cir. Feb. 19, 2014).
Wednesday, February 12, 2014
New Federal Circuit Opinions - February 12, 2014
Solvay S.A. v. Honeywell Int'l Inc., No. 2012-1660 (Fed. Cir. Feb. 12, 2014).
Monday, February 10, 2014
New Federal Circuit Opinions - February 10, 2014
Tempo Lighting, Inc. v. Tivoli, LLC, No. 2013-1140 (Fed. Cir. Feb. 10, 2014).
Friday, January 31, 2014
New Federal Circuit Opinions - January 31, 2014
EnOcean GmbH v. Face Int'l Corp., No. 2012-1645 (Fed. Cir. Jan. 31, 2014).
Wednesday, January 22, 2014
New Federal Circuit Opinions - January 22, 2014
Medtronic CoreValve, LLC v. Edwards Lifesciences Corp., No. 2013-1117 (Fed. Cir. Jan. 22, 2014).
Wednesday, January 15, 2014
New Federal Circuit Opinions - January 15, 2014
Novartis AG v. Lee, Nos. 2013-1160, -1179 (Fed. Cir. Jan. 15, 2014).
Monday, January 13, 2014
New Federal Circuit Opinions - January 13, 2014
In re Enhanced Security Research, No. 2013-1114 (Fed. Cir. Jan. 13, 2014).
In re Giannelli, No. 2013-1167 (Fed. Cir. Jan. 13, 2014).
Proveris Scientific Corp. v. Innovasystems, Inc., Nos. 2013-1166, -1190 (Fed. Cir. Jan. 13, 2014).
In re Giannelli, No. 2013-1167 (Fed. Cir. Jan. 13, 2014).
Proveris Scientific Corp. v. Innovasystems, Inc., Nos. 2013-1166, -1190 (Fed. Cir. Jan. 13, 2014).
Wednesday, January 8, 2014
New Federal Circuit Opinions - January 8, 2014
Pacific Coast Marine Windshields, Ltd. v. Malibu Boats, LLC, No. 2013-1199 (Fed. Cir. Jan. 8, 2014).
Subscribe to:
Posts (Atom)